PUTRAJAYA: The National Pharmaceutical Regulatory Agency (NPRA) has approved an extension for the shelf life of SinoVac's CoronaVac and Pfizer-BioNTech's Comirnaty Covid-19 vaccines, says Health director-general Tan Sri Dr Noor Hisham Abdullah.
He said NPRA had approved the respective applications from Pharmaniaga Lifescience Sdn Bhd and Pfizer (Malaysia) Sdn Bhd.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
